Abstract

Bloodstream infections (BSI) and sepsis are major causes of morbidity and mortality worldwide. Blood culture-based diagnostics usually requires 1–2 days for identification of bacterial agent and an additional 2–3 days for phenotypic determination of antibiotic susceptibility pattern. With the escalating burden of antimicrobial resistance (AMR) rapid diagnostics becomes increasingly important to secure adequate antibiotic therapy. Real-time whole genome sequencing represents a genotypic diagnostic approach with the ability to rapidly identify pathogens and AMR-encoding genes. Here we have used nanopore sequencing of bacterial DNA extracted from positive blood cultures for identification of pathogens, detection of plasmids and AMR-encoding genes. To our knowledge, this is the first study to gather the above-mentioned information from nanopore sequencing and conduct a comprehensive analysis for diagnostic purposes in real-time. Identification of pathogens was possible after 10 minutes of sequencing and all predefined AMR-encoding genes and plasmids from monoculture experiments were detected within one hour using raw nanopore sequencing data. Furthermore, we demonstrate the correct identification of plasmids and blaCTX-M subtypes using de novo assembled nanopore contigs. Results from this study hold great promise for future applications in clinical microbiology and for health care surveillance purposes.

Highlights

  • Antibiotics and the bacterial species[6]

  • Results obtained with Centrifuge and search by BLAST differed substantially

  • We have used the bacteria, archaea, virus and human indexing scheme for Centrifuge, which is derived from the NCBI Reference sequences (RefSeq) database

Read more

Summary

Introduction

Antibiotics and the bacterial species[6]. Use of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry is becoming widespread in clinical microbiology laboratories to identify bacteria by analysis of pelleted blood-cultures when they are flagged as positive by the blood culture incubation system[7]. The introduction of the real-time sequencing platform from Oxford nanopore technology (ONT) has triggered studies to explore its application in blood culture diagnostics, either based on 16 s amplicon sequencing[15], or by a whole-genome-sequencing approach[16] This represents an unbiased approach to diagnostics with the potential to identify any pathogen and AMR-encoding gene. We present results from rapid blood culture diagnostics based on extraction of bacterial DNA from positive blood cultures followed by nanopore sequencing and real-time data analysis for identification of pathogens, detection of plasmids and AMR-encoding genes. The results have been verified through WGS using short-read Illumina sequencing and hybrid assembly using nanopore and Illumina sequences This proof-of-concept study represents a molecular-genetic approach to diagnosis of BSIs which can provide clinicians with detailed information on etiologic agent and AMR within few hours of a blood culture becoming positive

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call